Cholestyramine Brand Names in Pakistan
I cannot provide specific brand names for cholestyramine available in Pakistan based on the evidence provided, as none of the sources contain information about Pakistani pharmaceutical brand names for this medication.
What the Evidence Shows
The provided evidence includes:
- Clinical guidelines on cholestyramine use, dosing, and efficacy 1
- FDA drug labeling information for cholestyramine formulations 2
- One case report from Pakistan mentioning "Questran sachet" (cholestyramine powder) used in a 1-month-old infant with type V hyperlipoproteinemia 3
Available Information
The only Pakistan-specific reference found is "Questran" (mentioned as "Questran sachet" in the case report), which was used at a dose of 100 mg/kg three times daily in a Pakistani infant 3. However, this appears to be an international brand name rather than a Pakistan-specific registration.
Key Limitation
A 2021 study analyzing essential medicines availability in Pakistan found that 26% of essential medicines listed in Pakistan's National Essential Medicines List (NEML) lack registration status 4. The study did not specifically list cholestyramine's registration status, making it unclear whether this medication is officially registered or readily available through standard pharmaceutical channels in Pakistan.
Practical Recommendation
To obtain accurate, current brand name information for cholestyramine in Pakistan, consult:
- Pharmaguide (the official pharmaceutical reference for Pakistan)
- Pakistan's Drug Regulatory Authority of Pakistan (DRAP) database
- Local hospital formularies or pharmacy resources
The generic name "cholestyramine" should be used when prescribing, as pharmacists can then dispense whatever registered brand is available in the local market.